• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Michael Lee, Australia

    Michael Lee, Australia

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • David Watson, Scotland

    David Watson, Scotland

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Olga, Argentina

    Olga, Argentina

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Liam Dwyer, England

    Liam Dwyer, England

  • Angelique van der Lit-van Veldhuizen, Netherlands

    Angelique van der Lit-van Veldhuizen, Netherlands

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Len Johnrose, England

    Len Johnrose, England

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • Alex, Argentina

    Alex, Argentina

  • Joanne Pratt, Australia

    Joanne Pratt, Australia

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Ali Var, Turkey

    Ali Var, Turkey

  • Dick Dayton, USA

    Dick Dayton, USA

  • Olga Cosentino, Argentina

    Olga Cosentino, Argentina

  • Bayley, Australia

    Bayley, Australia

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Frank Taylor, USA

    Frank Taylor, USA

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Steven Spencer, New Zealand

    Steven Spencer, New Zealand

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Maria Lucia Wood Saldanha, Brazil

    Maria Lucia Wood Saldanha, Brazil

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Jon Newsome, USA

    Jon Newsome, USA

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Monica Soriano, Argentina

    Monica Soriano, Argentina

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Cassio Fernando da Silva, Brazil

    Cassio Fernando da Silva, Brazil

  • Timmy, Belgium

    Timmy, Belgium

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Eddy LeFrançois, Canada

    Eddy LeFrançois, Canada

  • Danny Reviers, Belgium

    Danny Reviers, Belgium
    DannyReviers

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • Jason Goodman, USA

    Jason Goodman, USA

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login